Search

everythinglearnresearchcommunity

for

Search:↓

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

A boy with long QT syndrome was treated successfully, highlighting the need for careful evaluation of chest pain in children for heart conditions like LQTS.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.

Clq deficiency is linked to systemic lupus erythematosus symptoms.

The DLQI is a key tool for measuring quality of life in dermatology.

Low-Level Light Therapy improves quality of life more for women than men with hair loss.

There is a significant need for better-validated quality of life tools in dermatology.

Strict regulations may slow down new LLLT treatments.

Using both DLQI and Skindex-16 together gives a better understanding of quality of life in skin disease patients.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Combining iron supplements with Qilib lotion is more effective for treating hair loss from iron deficiency.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Iron supplements combined with Quilib lotion effectively treat hair loss in people with iron deficiency anemia.

Telogen effluvium most affects quality of life in alopecia patients.

Chemical lumbar sympathectomy is an effective and safe treatment for idiopathic livedo reticularis.

The review concluded that better studies are needed to prove if Low-Level Laser Therapy devices for hair growth really work.

QMSI effectively maps and quantifies drug distribution in skin tissues.

Early detection of Graham-Little-Piccardi-Lasseur syndrome is key for better management.

The AAcQLI is a promising tool for assessing quality of life in children with alopecia areata.

LLLT devices for hair loss need more research to define proper guidelines.

Low Level Laser Therapy can promote hair growth.

The Dermatology Life Quality Index is reliable and consistent but needs more diverse participant studies.

The electronic version of the Dermatology Life Quality Index is as effective as the paper version, with most patients preferring it.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

LLLT promotes hair growth and improves hair density safely in men and women.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.